A股異動丨密爾克衞(603713.SH)放量大漲8% 年度淨利增長近5成
格隆匯4月3日丨密爾克衞(603713.SH)今日放量大漲,盤中封漲停現已打開,目前漲8.07%,報55.7元,暫成交2.41億元,最新總市值86.19億元。密爾克衞1日公佈,2019年度淨利升48.35%至1.96億元,擬10派1.9元。營業總收入上升3主要因為2019年公司加大運輸網絡投入,運輸業務營收達到6.72億元。華泰證券點評稱,公司業績符合預期,佈局全國效果顯著。公司2019年末經營活動現金流淨額為2.13億元,同比增長63.29%,超過營業收入和淨利率增幅,説明公司業績增長質量較高。維持“增持”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.